The Rest Is Money

2. The drug behind Europe's most valuable company

Sep 6, 2023
The podcast discusses the economic effects of the RAAC debacle, a Danish company's success with a weight loss drug, the rise of 'buy now, pay later' services, dangerous materials in schools and infrastructure underinvestment, and the increase in profit margins of British businesses.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Gratitude to listeners and discussion of various topics
01:39 • 3min
3
The Success of Semaglutide: A Game Changer in Weight Loss and Diabetes Treatment
04:31 • 12min
4
Implications of Dangerous Material in Schools and Underinvestment in Infrastructure
16:21 • 11min
5
The Importance of Long-Term Thinking and Excessive Debt
26:52 • 2min
6
The Rise of Buy Now, Pay Later Services
28:29 • 25min
7
Discussion on Profit Margins, Windfall Tax, and British Business
53:34 • 2min